HCO3 bolus effective in reducing contrast nephropathy before emergent catheterization

In this small trial of patients undergoing emergent cardiac catheterization with renal insufficiency (CrCl<60 or Cr>1.1), they were randomized to normal saline or HCO3 bolus; the incidence of CIN was significantly lower in the HCO3 group (3% vs 28%); this can be an effective and efficient way to reduce the incidence of CIN before emergent dye loads (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment